ClinicalTrials.gg
Not yet recruitingNCT07183345Updated Jul 9, 2026

Application of Dynamic Pain Assessment and Management System in Perioperative Period of Patients With Incarcerated Mixed Hemorrhoids

An Early Phase 1 interventional study of Dynamic Pain Assessment and Management System and Routine drug analgesia in Incarcerated Mixed Hemorrhoids, sponsored by The Affiliated Hospital of Putian University. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-07-09.

Sponsored by The Affiliated Hospital of Putian University · Early Phase 1, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Early Phase 1
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This study aims to investigate whether the dynamic pain assessment and management system can alleviate postoperative pain in patients with incarcerated mixed hemorrhoids and reduce the incidence of complications. A total of 64 eligible patients were enrolled and randomly divided into two groups, with the specific grouping and intervention methods as follows:

① Control Group: Routine drug analgesia and conventional nursing education were adopted.

② Study Group: Patients were managed with the dynamic pain assessment and management system, which included preoperative administration of analgesic drugs, postoperative traditional Chinese medicine (TCM) fumigation, wrist-ankle acupuncture for pain relief, and personalized nursing education.

The study evaluated the effect of the dynamic pain assessment and management system on postoperative analgesia by comparing the Numerical Rating Scale (NRS) scores for pain, recording the Visual Analogue Scale (VAS) scores for quality of life, and analyzing the incidence of complications among patients in different groups. The primary hypothesis of the study is that, compared with routine pain management methods, the dynamic pain assessment and management system can significantly reduce postoperative pain in patients, improve their quality of life, and decrease the incidence of complications (such as bleeding and urinary retention).

02

Conditions studied

  • Incarcerated Mixed Hemorrhoids

Keywords

  • Pain Management
  • Preoperative Analgesia
  • Traditional Chinese Medicine (TCM) Fumigation
  • Wrist-Ankle Acupuncture (WAA)
  • Dynamic Pain Management
03

In context

Lead sponsor

The Affiliated Hospital of Putian University is the lead sponsor of 14 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 18 and 75 years old
  • Diagnosed with grade III-IV incarcerated mixed hemorrhoids according to the Goligher classification
  • Undergoing standard hemorrhoidectomy
  • Receiving simple intraspinal anesthesia

Exclusion criteria

Exclusion Criteria:

  • Pregnant or lactating patients
  • Patients receiving immunotherapy or with coagulation dysfunction
  • Patients who need to use various analgesic drugs daily
  • Complicated with other anorectal diseases (such as perianal abscess, anal fistula, anal incontinence)
  • Complicated with other systemic diseases (cardiac insufficiency; hepatic or renal insufficiency; diabetes mellitus; coagulation disorders; peptic ulcer, etc.)
  • Incomplete perioperative clinical data
  • Unable to cooperate with follow-up
05

Study design

Phase
Early Phase 1
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
64 participants (estimated)

Study arms

  • Other
    control group

    adopted routine drug analgesia

    Drug: Routine drug analgesia

  • Other
    study group

    Adoption of a Dynamic Pain Assessment and Management System

    Other: Dynamic Pain Assessment and Management System

Interventions

  • OtherDynamic Pain Assessment and Management System

    Personalized nursing education was adopted. These measures include the use of preoperative analgesic drugs, postoperative Traditional Chinese Medicine (TCM) fumigation, and wrist-ankle acupuncture for pain relief.

  • DrugRoutine drug analgesia

    adopted routine drug analgesia and conventional nursing education

06

What researchers measure

Primary outcomes

  1. Pain Numerical Rating Scale (NRS)

    The NRS uses a linear numerical range of "0 to 10" to represent pain intensity. Patients select the corresponding number based on their own perception, where a score of 0 indicates no pain at all, and a score of 10 represents the most severe pain you can imagine.

    Time frame: Baseline, Day 1, 3, 5, 7, and Day 14±2

Secondary outcomes

  1. Incidence Rate of Complications

    Measurements include the incidence rate of complications such as postoperative hemorrhage and urinary retention

    Time frame: within 30 days after surgery

  2. Length of Hospital Stay

    with hours as the unit, and standardized discharge criteria are adopted.

    Time frame: from the end of surgery to discharge (a maximum of 7 days)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Based on a strict commitment to participant privacy protection, compliance with the terms of the ethical review protocol, and adherence to the sponsoring institution's policies, IPD from this study will not be shared at this time.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026; primary completion for Sep 2026, 0 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 11, 2025
First posted
Sep 19, 2025
StartEst.
Sep 1, 2026
Primary completionEst.
Sep 1, 2026
CompletionEst.
May 31, 2028
Last update
Jul 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07183345
Lead sponsor
The Affiliated Hospital of Putian University
Responsible party
Sponsor
First posted
Sep 19, 2025
Start date
Sep 1, 2026 (estimated)
Primary completion
Sep 1, 2026 (estimated)
Completion
May 31, 2028 (estimated)
Last update
Jul 9, 2026

Study contacts

Chenxing Jian
Contact
ptyyjcx@126.com
+8613959538950

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion